Related Experiment Video
Updated: Jul 13, 2026

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins
Gary Potikyan1, Rupert O V Savene, Julie M Gaulden
1Molecular Biology Institute, Jonsson Comprehensive Cancer Center, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90024, USA.
Abstract:
Suppression of the expression of antiangiogenic factors has been closely associated with multiple malignancies. Thrombospondins 1 and 2 are members of a family of angiogenic inhibitors that are regulated by several oncogenes. In this study, we investigate the role of thrombospondins in Ewing's sarcoma and their regulation by EWS/ETS fusion oncoproteins. We show that the EWS/FLI1 fusion suppresses the expression of thrombospondins in both NIH3T3 fibroblasts and Ewing's sarcoma tumor-derived cell lines. This regulation depends on an intact EWS/FLI1 DNA-binding domain and may involve direct interactions between EWS/FLI1 and thrombospondin promoter regions. Forced expression of thrombospondins in Ewing's sarcoma cell lines inhibited the rate of tumor formation in vivo and markedly decreased the number of microvessels present in the tumors. These findings suggest that thrombospondins play a biologically significant role in tumor vascularization in Ewing's sarcoma and suggest potential therapeutic strategies for future therapeutic intervention.
Insights
Thrombospondins, natural angiogenesis inhibitors, are suppressed by EWS/FLI1 in Ewing sarcoma. Restoring thrombospondins reduced tumor growth and vascularization, indicating their therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Suppression of antiangiogenic factors is linked to malignancies.
- Thrombospondins 1 and 2 are key inhibitors of angiogenesis regulated by oncogenes.
Purpose of the Study:
- To investigate the role of thrombospondins in Ewing sarcoma.
- To determine how EWS/ETS fusion oncoproteins regulate thrombospondins.
Main Methods:
- Investigated EWS/FLI1 regulation of thrombospondins in cell lines.
- Analyzed EWS/FLI1 DNA-binding domain and promoter interactions.
- Assessed the impact of forced thrombospondin expression on tumor formation in vivo.
Main Results:
- EWS/FLI1 fusion protein suppresses thrombospondin expression in Ewing sarcoma cells.
- This suppression requires an intact EWS/FLI1 DNA-binding domain.
- Forced thrombospondin expression inhibited tumor growth and reduced microvessel density in vivo.
Conclusions:
- Thrombospondins play a significant role in Ewing sarcoma vascularization.
- Targeting thrombospondin regulation offers potential therapeutic strategies for Ewing sarcoma.
More Related Videos
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
09:03Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
The Tumor Microenvironment
Intracellular Signaling Affects Focal Adhesions
Some...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Mechanism of Angiogenesis
Non-Canonical Wnt Signaling Pathways